Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (2407)	2/19/1998 6:35:00 AM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

Brad, Let's leave the question of fraud out of this issue. I think it's unfortunate that Bill Wexler has "spoiled" the discussion with repeating his opinion of "fraud and scam, and filthy crook." The question was raised by the Wessels... report of efficacy. If their report is accurate, the drug doesn't work in moderate and low dosages and has severe side effects in high dosages. This failure at Phase III is very serious, in my experience as an investor. I owned LIPO when their major drug failed Phase III, was found to be ineffective. The stock went from my purchase price of 26 to around 5. That was some time ago, and now, even with other drugs of theirs doing well, the stock is 5-3/4. As a result of having been burned as a stockholder, I consider failure in Phase III to be very serious. Linda